---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-038047"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:04:13.850617+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Moleculin Biotech regains Nasdaq bid price compliance after stock closes at $1.00+ for 10 days

## Summary
- Nasdaq confirmed compliance with Listing Rule 5550(a)(2) effective Dec 15, 2025.
- Cure based on closing bid price at or above $1.00 for 10 consecutive days ending Dec 12.
- Previous deficiency notice from June 27, 2025 is now closed.

## SEC filing metadata
- accession: 0001437749-25-038047
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774925038047/0001437749-25-038047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774925038047/mbrx20251215_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-038047
- JSON: https://secwatch.observer/filing/0001437749-25-038047.json
- Plain text: https://secwatch.observer/filing/0001437749-25-038047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.